Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Bhavya Bhavya, Md

Clinical trials sponsored by Bhavya Bhavya, Md, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Which diabetes drug wins? new study pits dapagliflozin vs empagliflozin Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Not yet recruiting 1

Which diabetes drug wins? new study pits dapagliflozin vs empagliflozin

Disease control Not yet recruiting

This study compares two common diabetes drugs, dapagliflozin and empagliflozin, to see which works better for lowering blood sugar and weight in people with type 2 diabetes and a high body mass index. About 112 adults will take one of the two drugs for six months. Researchers wil…

Phase 4 • Sponsor: Bhavya Bhavya, MD • Aim: Disease control

Last updated Jun 27, 2026 08:07 UTC